{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:26:34Z","timestamp":1790321194038,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejim.2010.12.017","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T04:35:24Z","timestamp":1296102924000},"page":"134-140","source":"Crossref","is-referenced-by-count":81,"title":["Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet"],"prefix":"10.1016","volume":"22","author":[{"given":"Stephanie","family":"Seneff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mascitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2010.12.017_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejim.2010.12.017_bb0010","unstructured":"Eli Lilly and Company, 2010 PR Newswire, Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials, August 17, 2010, http:\/\/newsroom.lilly.com\/releasedetail.cfm?releaseid=499794 (accessed on December 07, 2010)."},{"key":"10.1016\/j.ejim.2010.12.017_bb0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0020","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn.2511","article-title":"Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease","volume":"13","author":"Fuhrmann","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejim.2010.12.017_bb0035","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.22-07-02434.2002","article-title":"Noradrenergic depletion potentiates \u03b2-amyloid-induced cortical inflammation: implications for Alzheimer's disease","volume":"22","author":"Heneka","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.arr.2005.02.003","article-title":"Glucose metabolism and Alzheimer's disease","volume":"4","author":"Schubert","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejim.2010.12.017_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2014is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejim.2010.12.017_bb0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10863-009-9244-4","article-title":"Mitochondria and Alzheimer's disease: amyloid-\u03b2 peptide uptake and degradation by the presequence protease, hPreP","volume":"41","author":"Alikhani","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ejim.2010.12.017_bb0055","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejim.2010.12.017_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mito.2005.01.002","article-title":"Mitochondrial dysfunction and its role in motor neuron degeneration in ALS","volume":"5","author":"Manfredi","year":"2005","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejim.2010.12.017_bb0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nm0904-905","article-title":"Maiming mitochondria in familial ALS","volume":"10","author":"Dawson","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejim.2010.12.017_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0005-2736(03)00024-5","article-title":"Role of cholesterol in synapse formation and function","volume":"1610","author":"Pfrieger","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejim.2010.12.017_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer's disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejim.2010.12.017_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apoliporotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.ejim.2010.12.017_bb0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","article-title":"Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice","volume":"39","author":"DeMattos","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejim.2010.12.017_bb0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.138.4.877","article-title":"A new function for the LDL receptor: transcytosis of LDL across the blood\u2013brain barrier","volume":"13","author":"Dehouck","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","article-title":"Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes","volume":"88","author":"Rapp","year":"2006","journal-title":"Biochimie"},{"key":"10.1016\/j.ejim.2010.12.017_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejim.2010.12.017_bb0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(97)04430-9","article-title":"Total cholesterol and risk of mortality in the oldest old","volume":"350","author":"Weverling-Rijnsburger","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2010.12.017_bb0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/JGP.0b013e3181812790","article-title":"Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele","volume":"16","author":"West","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejim.2010.12.017_bb0125","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000161870.78572.A5","article-title":"High total cholesterol levels in late life associated with a reduced risk of dementia","volume":"64","author":"Mielke","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2010.12.017_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00002093-199809000-00012","article-title":"Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4","volume":"12","author":"Mulder","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejim.2010.12.017_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7827(01)00009-1","article-title":"Do sterols reduce proton and sodium leaks through lipid bilayers?","volume":"40","author":"Haines","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejim.2010.12.017_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jalz.2008.12.001","article-title":"Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?","volume":"5","author":"Honjo","year":"2009","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ejim.2010.12.017_bb0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/0891988707301867","article-title":"Characterization of the lipid profile in dementia and depression in the elderly","volume":"20","author":"Dimopoulos","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu\u2013Asia Aging Study","volume":"23","author":"Huang","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejim.2010.12.017_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0939-4753(04)80047-4","article-title":"Diet for preventing cardiovascular diseases: light from Ancel Keys, distinguished centenarian scientist","volume":"14","author":"Mancini","year":"2004","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ejim.2010.12.017_bb0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G","article-title":"Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis","volume":"54","author":"Michikawa","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejim.2010.12.017_bb0165","unstructured":"Seneff S, Wainwright G, Mascitelli L. Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet? Arch Med Sci (in press)."},{"key":"10.1016\/j.ejim.2010.12.017_bb0170","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jn\/128.9.1442","article-title":"Long-term fructose consumption accelerates glycation and several age-related variables in male rats","volume":"128","author":"Levi","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejim.2010.12.017_bb0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MOL.0b013e328306a057","article-title":"Glycation as an atherogenic modification of LDL","volume":"19","author":"Younis","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0180","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1042\/bst0311423","article-title":"Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats","volume":"31","author":"Karachalias","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejim.2010.12.017_bb0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1388-1981(02)00188-9","article-title":"Early glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates","volume":"1583","author":"Laffont","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejim.2010.12.017_bb0190","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2010.12.017_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205043480555","article-title":"The clinical and biological relationship between type II diabetes mellitus and Alzheimer's disease","volume":"1","author":"Nicolls","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejim.2010.12.017_bb0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cmet.2010.11.006","article-title":"Diabetes and insulin in regulation of brain cholesterol metabolism","volume":"12","author":"Suzuki","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejim.2010.12.017_bb0205","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu\u2013Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2010.12.017_bb0210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0165-0173(02)00273-4","article-title":"Glycation: a sweet tempter for neuronal death","volume":"41","author":"Kikuchi","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejim.2010.12.017_bb0215","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.ejim.2010.12.017_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0197-4580(00)00253-0","article-title":"Increased protein glycation in cerebrospinal fluid of Alzheimer's disease","volume":"22","author":"Shuvaev","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejim.2010.12.017_bb0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(97)00266-8","article-title":"Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease","volume":"226","author":"Li","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejim.2010.12.017_bb0230","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept","volume":"37","author":"Bierhaus","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejim.2010.12.017_bb0235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0240","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(97)04318-3","article-title":"Association of apolipoprotein E polymorphism with outcome after head injury","volume":"350","author":"Teasdale","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2010.12.017_bb0245","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0250","first-page":"289","article-title":"Cholesterol-lowering therapies and cell membranes. Stable plaque at the expense of unstable membranes?","volume":"5","author":"Wainwright","year":"2009","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ejim.2010.12.017_bb0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-5-4","article-title":"Amyloid\u2013beta-acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease","volume":"5","author":"Dinamarca","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ejim.2010.12.017_bb0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejim.2010.12.017_bb0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(98)00039-4","article-title":"Blood glutamate levels in patients with motor neuron disease","volume":"273","author":"Babu","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejim.2010.12.017_bb0270","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1073\/pnas.0813138106","article-title":"A scissors mechanism for stimulation of SNARE-mediated lipid mixing by cholesterol","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.ejim.2010.12.017_bb0275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12031-010-9351-z","article-title":"Cholesterol depletion from the plasma membrane impairs proton and glutamate storage in synaptic vesicles of nerve terminals","volume":"41","author":"Tarasenko","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0280","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuint.2009.12.006","article-title":"Cholesterol depletion attenuates tonic release but increases the ambient level of glutamate in rat brain synaptosomes","volume":"56","author":"Borisova","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejim.2010.12.017_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2006.05.081","article-title":"Cholesterol deficiency perturbs actin signaling and glutamate homeostasis in hippocampal astrocytes","volume":"1104","author":"Tsai","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejim.2010.12.017_bb0290","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/00001756-199510020-00013","article-title":"\u03b2-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease","volume":"6","author":"Harris","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejim.2010.12.017_bb0295","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1073\/pnas.89.17.8264","article-title":"Growth factors and vitamin E modify neuronal glutamate toxicity","volume":"89","author":"Schubert","year":"1992","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.ejim.2010.12.017_bb0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-008-0012-2","article-title":"Why lipids are important for Alzheimer disease?","volume":"326","author":"Hirsch-Reinshagen","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejim.2010.12.017_bb0305","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of A\u03b2","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ejim.2010.12.017_bb0310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejim.2010.12.017_bb0315","doi-asserted-by":"crossref","first-page":"R372","DOI":"10.1152\/ajpregu.00401.2001","article-title":"Primary causes of decreased mitochondrial oxygen consumption during metabolic depression in snail cells","volume":"282","author":"Bishop","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0320","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid-\u03b2 oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejim.2010.12.017_bb0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2202-8-84","article-title":"Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons","volume":"8","author":"Storozhevykh","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0330","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/ars.2005.7.1021","article-title":"Role of insulin-induced reactive oxygen species in the insulin signaling pathway","volume":"7","author":"Goldstein","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejim.2010.12.017_bb0335","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-\u03b2 peptide levels in brain are inversely correlated with insulysin activity levels in vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.ejim.2010.12.017_bb0340","doi-asserted-by":"crossref","first-page":"H2417","DOI":"10.1152\/ajpheart.2001.281.6.H2417","article-title":"A \u03b2-peptides enhance vasoconstriction in cerebral circulation","volume":"281","author":"Niwa","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0345","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","article-title":"Amyloid \u03b2-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation","volume":"17","author":"Mark","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0350","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0925-4439(00)00041-7","article-title":"Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid \u03b2-peptide","volume":"1502","author":"Yan","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 1","key":"10.1016\/j.ejim.2010.12.017_bb0355","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/0264-6021:3450139","article-title":"Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase","volume":"345","author":"He","year":"2000","journal-title":"Biochem. J."},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2010.12.017_bb0360","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1186\/1471-2202-9-S2-S16","article-title":"Hypometabolism as a therapeutic target in Alzheimer's disease","volume":"9","author":"Costantini","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0365","first-page":"584","article-title":"Neurodegenerative disease: high fat lightens the load","volume":"9","author":"Nicholson","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejim.2010.12.017_bb0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuint.2005.04.014","article-title":"Response of brain amino acid metabolism to ketosis","volume":"47","author":"Yudkoff","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejim.2010.12.017_bb0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9150(01)00660-8","article-title":"Statins inhibit A \u03b2-neurotoxicity in vitro and A\u03b2-induced vasoconstriction and inflammation in rat aortae","volume":"161","author":"Paris","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2010.12.017_bb0380","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000017324","article-title":"Evidence supporting the existence of an activity-dependent astrocyte\u2013neuron lactate shuttle","volume":"20","author":"Pellerin","year":"1998","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0385","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1365-2362.2001.00911.x","article-title":"In vitro effect of advanced glycation end-products on human polymorphonuclear superoxide production","volume":"31","author":"Bernheim","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2010.12.017_bb0390","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/11310910-000000000-00000","article-title":"Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"23","author":"Holmes","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejim.2010.12.017_bb0395","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/00207450902782083","article-title":"Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease","volume":"119","author":"Kountouras","year":"2009","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejim.2010.12.017_bb0400","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00415-009-5011-z","article-title":"Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease","volume":"256","author":"Kountouras","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejim.2010.12.017_bb0405","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-2008-13403","article-title":"Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease","volume":"13","author":"Balin","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejim.2010.12.017_bb0410","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.mehy.2008.07.005","article-title":"Can phages cause Alzheimer's disease?","volume":"71","author":"Dezfulian","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejim.2010.12.017_bb0415","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2010.12.017_bb0420","unstructured":"Waldman M. Are we experiencing an Alzheimer's epidemic? AD\/PD 2009: 9th International Conference on Alzheimer's and Parkinson's Diseases: Abstract 90. Presented March 12\u201313, 2009. www.medscape.com\/viewarticle\/590106 (accessed on December 07, 2010)."},{"key":"10.1016\/j.ejim.2010.12.017_bb0425","unstructured":"Alzheimer's Society. 2010 Alzheimer's disease facts and figures. http:\/\/www.alz.org\/documents_custom\/report_alzfactsfigures2010.pdf (accessed on December 07, 2010)."},{"key":"10.1016\/j.ejim.2010.12.017_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.cdd.4401528","article-title":"Amyloid \u03b2 induces neuronal cell death through ROS-mediated ASK1 activation","volume":"12","author":"Kadowaki","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejim.2010.12.017_bb0435","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1023\/A:1007675508413","article-title":"The endosomal\u2013lysosomal system of neurons in Alzheimer's disease pathogenesis: a review","volume":"25","author":"Nixon","year":"2000","journal-title":"Neurochem. Res."}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:41:32Z","timestamp":1559954492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0953620511000045"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2010.12.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}